Actionable news
0
All posts from Actionable news
Actionable news in ESPR: Esperion Therapeutics, Inc.,

Esperion Therapeutics Inc.

GO

Average Recommendation: Buy Average Target Price: 77.92
Number of Ratings: 12 Current Quarters Estimate: -0.60
FY Report Date: 12 / 2015 Current Year's Estimate: -2.40
Last Quarter's Earnings: N/A Median PE on CY...

More